Everything i post is my personal opinion and is not financial advice ! I will not be held accountable for any post that are incorrect or inaccurate !
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DAVID FOLEY FOUND GUILTY OF FRAUD (LINK) PLEASE READ!
Im not a shortie nor am i an investor of NTEK was intill i found out about this.. and BANKSHOT is exposing alot of hidden details about this company that investors should look at and learn so they dont get BURNT! lol good luck all your CEO IS A FRUAD!
READ THE FACTS IM NOT MAKING THIS UP PEOPLE!
http://dougberry.hubpages.com/hub/Ultracade-Founder-David-Foley-Found-Guilty-of-Fraud
SELL SELL SELL *READ* NTEK INVESTOR'S
David Foley, founder of Ultracade, pled guilty to conspiracy to commit fraud and other charges January 9, 2012.
Source: klov.com
Link - > http://dougberry.hubpages.com/hub/Ultracade-Founder-David-Foley-Found-Guilty-of-Fraud
NTEK CEO = SCAM David Foley Pleads Guilty to Conspiracy to Commit Fraud and Other Charges
http://dougberry.hubpages.com/hub/Ultracade-Founder-David-Foley-Found-Guilty-of-Fraud
Good Morning NTEK'ers :D !
NTEK -HUGE NEWS OUT!(NTEK) ANNOUNCES EUROPEAN GAMING PARTNER
NANOTECH ENTERTAINMENT (OTCPINK: NTEK) today announced from the Amusement Expo 2013 that it has reached an exclusive agreement with London based Electrocoin Sales LTD to manufacture, sell and distribute its line of coin-op and gaming products. With many new products and technologies destined for the gaming market, NanoTech CEO Jeffrey A. Foley stated, "We are thrilled to be working with one of the most prestigious names in the European amusement business."
NTEK -HUGE NEWS OUT!(NTEK) ANNOUNCES EUROPEAN GAMING PARTNER
NANOTECH ENTERTAINMENT (OTCPINK: NTEK) today announced from the Amusement Expo 2013 that it has reached an exclusive agreement with London based Electrocoin Sales LTD to manufacture, sell and distribute its line of coin-op and gaming products. With many new products and technologies destined for the gaming market, NanoTech CEO Jeffrey A. Foley stated, "We are thrilled to be working with one of the most prestigious names in the European amusement business."
HUGE NEWS OUT!!!!!
South Street Media, Inc. Released The Press And Probily Got Paid For It. Which Means Promoter's Probily Touting This Stock. Good Luck Every One Still In It Do You DD
Hate To Tell Yall But There Last Press Release Was Released Basically By A Paid Third Party Site. (RED FLAG)
[[[[[ READ BOTTOM LINE PEOPLE ]]]]]]
reeneStone Healthcare Corporation (OTCBB:GRST) ("GreeneStone" or the "Company"), provider of Healthcare services and operator of several mental health clinics, announced the expansion of its services to include surgery. The Company will move forward with a multi-year lease extension at its North York facility which will allow the Company to make the investment in the addition of a surgical suite. This strategy was previously announced when the Company hired Dr. Chaklader, a Gastroenterologist who completed her Fellowship in Nutrition. Dr. Chaklader has been an important addition to GreeneStone's Endoscopy practice whose invaluable training in internal medicine and nutrition has helped the Company establish a 'Gastrointestinal Centre of Excellence.'
The surgical suite will be a Level 3 Out of Hospital Premise (OHP) as described in the guidelines of the College of Physicians and Surgeons (CPSO). This surgical suite will allow the Company to perform gastric banding as a natural extension to its gastroenterology work. It will also allow the Company to earn income from other non-related procedures such as plastic surgery. This additional revenue leverages much of our infrastructure at this clinic and will improve the bottom line. This suite is expected to be on line in the third quarter of 2013.
This specialization will be the foundation for building towards the Company's goal of providing services that will tackle the increasing problems of obesity and Type II diabetes. Shawn Leon, the company's President and CEO, commented, "We are sewing these threads together to increase the services offered to the Company's growing list of corporate clients as we continue to provide solutions to reduce corporate healthcare and disability costs. We believe this will be the most effective way to grow revenue quickly."
About GreeneStone Healthcare Corporation
GreeneStone Healthcare Corporation (OTCBB:GRST) operates medical and healthcare clinics in Ontario, Canada. GreeneStone's clinics serve to add overflow capacity to an increasingly stretched provincial healthcare system, and provide private alternatives to publicly available healthcare services. Its four medical clinics (three in Toronto, along with a facility in Muskoka, Ontario) offer various medical services, including addiction treatment, endoscopy, minor cosmetic procedures, and executive health care services. The company currently has more than 60 employees and is based in North York, Ontario.
Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act"). To the extent that any statements made in this press release contain information that is not historical, these statements are essentially forward-looking. Forward-looking statements can be identified by the use of words such as "expect," "plan," "will," "may," "anticipate," "believe," "should," "intend," "estimate," and variations of such words. Forward-looking statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, those risks and uncertainties contained in this press release and those identified in the periodic reports that the company files with the Securities and Exchange Commission (the "SEC") pursuant to the Exchange Act.
CONTACT: Investor information and email sign-up:
Shawn Leon (416) 222 5501
shawn@greenestone.net
www.greenestone.net
-->>>>> Melissa Diaz, South Street Media, Inc.
Phone: (917) 937-8968
Email: info@southstreetmedia.com
Mondays gonna be a nice day
GRST Price Traget Issued @ .80 Chart's+DD
Investor Update: Updated March 15, 2013
GRST Upgraded Based on Expansion of Treatement Facilities, Earnings Watch
(NEW YORK)--Ludlow Research, a New York based equity research firm has updated its research opinion on Greenestone Healthcare Corp. (OTC:GRST), a provider of addiction treatment clinic centers in Canada, with a new tentative price target of $0.80 per share.
GRST was upgraded on the heels of their news that they have received endorsement from Ontario Police Department for their treatment of Post Traumatic Stress Disorder (PTSD), and execution of new facility that will focus specifically on this ailment. In addition, GRST is expected to report their financial earnings in the coming weeks, thus Ludlow Research is projecting positive revenue results based on their previous growth rates.
Investor Highlights
- Revenues Increasing Sharply
- Net Loss Decreasing
- On Track to Profitability
- Expanding Addiction Treatment Centers
- Target of $0.80 Issued
Greenestone Healthcare primary business is providing and managing addiction treatment centers in Canada. Currently the company operates 4 clinics, and is expected to increase these operation centers dramatically in the coming months through acquisitions. Since opening their first clinic in 2011, the company has experienced a sharp increase in revenues, and based on their growth looks primed to move into profitability within the coming months of 2013.Current
Financial Earnings
For the nine months ending Set. 30, 2012, the Company reported total revenues increased nearly 300% to $3,941,360, as compared to $1,017,431 for the same time period in 2011. For the same period, total net loss decreased nearly 33% from ($1,051,536), or ($0.07) EPS, for the nine months ending Sept. 30, 2012, compared to a net loss of ($1,767,735), or ($0.33) EPS, for the same period in 2011.
GreeneStone opened its addiction treatment center in the third quarter of 2011, and took its first patients in July and August, most of which were done at nominal or no fee. Clients began to increase in September at a steady pace and the company generated $213,035 in revenue from the treatment center during the third quarter of 2011. Revenue in the third quarter of 2012 grew to $884,036, a 315% increase over the same period the previous year, with revenue in the third quarter was only slightly better than the revenue in the second quarter. Revenue in the third quarter was impacted by a very slow period in the middle of the summer, and the company has learned that this is a traditionally slow period in the addiction treatment business and will be better prepared in the coming year for this type of slowdown.
The Company is seeking to significantly increase its capacity at its in-patient treatment facility from 36 beds to 300 beds over the next twenty four months.
Share Structure
As of Feb. 18, 2013, the Company has around 24 million shares issued and outstanding, of which around 16.5 million was held by insiders and restricted from resale, and a public float of around 7.5million shares.
Valuation Target
Based on their revenue growth rate, plans to expand bed capacity to 200 beds, launch of treatment facility for PTSD, and tight public float and technical indicators on chart, Ludlow Research has upgraded their valuation target on GRST to $0.80 per share.
Investor Mailing List and Feedback Form
If you would like to be added to GRST investor mailing list to receive updates on news, upcoming events, research notes, or to submit a question to the company, please register online at http://www.wallstreetnewscast.com/request/grst.html
GRST Price Traget Issued @ .80 Chart's+DD
Investor Update: Updated March 15, 2013
GRST Upgraded Based on Expansion of Treatement Facilities, Earnings Watch
(NEW YORK)--Ludlow Research, a New York based equity research firm has updated its research opinion on Greenestone Healthcare Corp. (OTC:GRST), a provider of addiction treatment clinic centers in Canada, with a new tentative price target of $0.80 per share.
GRST was upgraded on the heels of their news that they have received endorsement from Ontario Police Department for their treatment of Post Traumatic Stress Disorder (PTSD), and execution of new facility that will focus specifically on this ailment. In addition, GRST is expected to report their financial earnings in the coming weeks, thus Ludlow Research is projecting positive revenue results based on their previous growth rates.
Investor Highlights
- Revenues Increasing Sharply
- Net Loss Decreasing
- On Track to Profitability
- Expanding Addiction Treatment Centers
- Target of $0.80 Issued
Greenestone Healthcare primary business is providing and managing addiction treatment centers in Canada. Currently the company operates 4 clinics, and is expected to increase these operation centers dramatically in the coming months through acquisitions. Since opening their first clinic in 2011, the company has experienced a sharp increase in revenues, and based on their growth looks primed to move into profitability within the coming months of 2013.Current
Financial Earnings
For the nine months ending Set. 30, 2012, the Company reported total revenues increased nearly 300% to $3,941,360, as compared to $1,017,431 for the same time period in 2011. For the same period, total net loss decreased nearly 33% from ($1,051,536), or ($0.07) EPS, for the nine months ending Sept. 30, 2012, compared to a net loss of ($1,767,735), or ($0.33) EPS, for the same period in 2011.
GreeneStone opened its addiction treatment center in the third quarter of 2011, and took its first patients in July and August, most of which were done at nominal or no fee. Clients began to increase in September at a steady pace and the company generated $213,035 in revenue from the treatment center during the third quarter of 2011. Revenue in the third quarter of 2012 grew to $884,036, a 315% increase over the same period the previous year, with revenue in the third quarter was only slightly better than the revenue in the second quarter. Revenue in the third quarter was impacted by a very slow period in the middle of the summer, and the company has learned that this is a traditionally slow period in the addiction treatment business and will be better prepared in the coming year for this type of slowdown.
The Company is seeking to significantly increase its capacity at its in-patient treatment facility from 36 beds to 300 beds over the next twenty four months.
Share Structure
As of Feb. 18, 2013, the Company has around 24 million shares issued and outstanding, of which around 16.5 million was held by insiders and restricted from resale, and a public float of around 7.5million shares.
Valuation Target
Based on their revenue growth rate, plans to expand bed capacity to 200 beds, launch of treatment facility for PTSD, and tight public float and technical indicators on chart, Ludlow Research has upgraded their valuation target on GRST to $0.80 per share.
Investor Mailing List and Feedback Form
If you would like to be added to GRST investor mailing list to receive updates on news, upcoming events, research notes, or to submit a question to the company, please register online at http://www.wallstreetnewscast.com/request/grst.html
( GRST ) Investor Update: Updated March 15, 2013
Investor Update: Updated March 15, 2013
GRST Upgraded Based on Expansion of Treatement Facilities, Earnings Watch
(NEW YORK)--Ludlow Research, a New York based equity research firm has updated its research opinion on Greenestone Healthcare Corp. (OTC:GRST), a provider of addiction treatment clinic centers in Canada, with a new tentative price target of $0.80 per share.
GRST was upgraded on the heels of their news that they have received endorsement from Ontario Police Department for their treatment of Post Traumatic Stress Disorder (PTSD), and execution of new facility that will focus specifically on this ailment. In addition, GRST is expected to report their financial earnings in the coming weeks, thus Ludlow Research is projecting positive revenue results based on their previous growth rates.
Investor Highlights
- Revenues Increasing Sharply
- Net Loss Decreasing
- On Track to Profitability
- Expanding Addiction Treatment Centers
- Target of $0.80 Issued
Greenestone Healthcare primary business is providing and managing addiction treatment centers in Canada. Currently the company operates 4 clinics, and is expected to increase these operation centers dramatically in the coming months through acquisitions. Since opening their first clinic in 2011, the company has experienced a sharp increase in revenues, and based on their growth looks primed to move into profitability within the coming months of 2013.Current
Financial Earnings
For the nine months ending Set. 30, 2012, the Company reported total revenues increased nearly 300% to $3,941,360, as compared to $1,017,431 for the same time period in 2011. For the same period, total net loss decreased nearly 33% from ($1,051,536), or ($0.07) EPS, for the nine months ending Sept. 30, 2012, compared to a net loss of ($1,767,735), or ($0.33) EPS, for the same period in 2011.
GreeneStone opened its addiction treatment center in the third quarter of 2011, and took its first patients in July and August, most of which were done at nominal or no fee. Clients began to increase in September at a steady pace and the company generated $213,035 in revenue from the treatment center during the third quarter of 2011. Revenue in the third quarter of 2012 grew to $884,036, a 315% increase over the same period the previous year, with revenue in the third quarter was only slightly better than the revenue in the second quarter. Revenue in the third quarter was impacted by a very slow period in the middle of the summer, and the company has learned that this is a traditionally slow period in the addiction treatment business and will be better prepared in the coming year for this type of slowdown.
The Company is seeking to significantly increase its capacity at its in-patient treatment facility from 36 beds to 300 beds over the next twenty four months.
Share Structure
As of Feb. 18, 2013, the Company has around 24 million shares issued and outstanding, of which around 16.5 million was held by insiders and restricted from resale, and a public float of around 7.5million shares.
Valuation Target
Based on their revenue growth rate, plans to expand bed capacity to 200 beds, launch of treatment facility for PTSD, and tight public float and technical indicators on chart, Ludlow Research has upgraded their valuation target on GRST to $0.80 per share.
Investor Mailing List and Feedback Form
If you would like to be added to GRST investor mailing list to receive updates on news, upcoming events, research notes, or to submit a question to the company, please register online at http://www.wallstreetnewscast.com/request/grst.html
( GRST ) Investor Update: Updated March 15, 2013
Investor Update: Updated March 15, 2013
GRST Upgraded Based on Expansion of Treatement Facilities, Earnings Watch
(NEW YORK)--Ludlow Research, a New York based equity research firm has updated its research opinion on Greenestone Healthcare Corp. (OTC:GRST), a provider of addiction treatment clinic centers in Canada, with a new tentative price target of $0.80 per share.
GRST was upgraded on the heels of their news that they have received endorsement from Ontario Police Department for their treatment of Post Traumatic Stress Disorder (PTSD), and execution of new facility that will focus specifically on this ailment. In addition, GRST is expected to report their financial earnings in the coming weeks, thus Ludlow Research is projecting positive revenue results based on their previous growth rates.
Investor Highlights
- Revenues Increasing Sharply
- Net Loss Decreasing
- On Track to Profitability
- Expanding Addiction Treatment Centers
- Target of $0.80 Issued
Greenestone Healthcare primary business is providing and managing addiction treatment centers in Canada. Currently the company operates 4 clinics, and is expected to increase these operation centers dramatically in the coming months through acquisitions. Since opening their first clinic in 2011, the company has experienced a sharp increase in revenues, and based on their growth looks primed to move into profitability within the coming months of 2013.Current
Financial Earnings
For the nine months ending Set. 30, 2012, the Company reported total revenues increased nearly 300% to $3,941,360, as compared to $1,017,431 for the same time period in 2011. For the same period, total net loss decreased nearly 33% from ($1,051,536), or ($0.07) EPS, for the nine months ending Sept. 30, 2012, compared to a net loss of ($1,767,735), or ($0.33) EPS, for the same period in 2011.
GreeneStone opened its addiction treatment center in the third quarter of 2011, and took its first patients in July and August, most of which were done at nominal or no fee. Clients began to increase in September at a steady pace and the company generated $213,035 in revenue from the treatment center during the third quarter of 2011. Revenue in the third quarter of 2012 grew to $884,036, a 315% increase over the same period the previous year, with revenue in the third quarter was only slightly better than the revenue in the second quarter. Revenue in the third quarter was impacted by a very slow period in the middle of the summer, and the company has learned that this is a traditionally slow period in the addiction treatment business and will be better prepared in the coming year for this type of slowdown.
The Company is seeking to significantly increase its capacity at its in-patient treatment facility from 36 beds to 300 beds over the next twenty four months.
Share Structure
As of Feb. 18, 2013, the Company has around 24 million shares issued and outstanding, of which around 16.5 million was held by insiders and restricted from resale, and a public float of around 7.5million shares.
Valuation Target
Based on their revenue growth rate, plans to expand bed capacity to 200 beds, launch of treatment facility for PTSD, and tight public float and technical indicators on chart, Ludlow Research has upgraded their valuation target on GRST to $0.80 per share.
Investor Mailing List and Feedback Form
If you would like to be added to GRST investor mailing list to receive updates on news, upcoming events, research notes, or to submit a question to the company, please register online at http://www.wallstreetnewscast.com/request/grst.html
( GRST ) Investor Update: Updated March 15, 2013
Investor Update: Updated March 15, 2013
GRST Upgraded Based on Expansion of Treatement Facilities, Earnings Watch
(NEW YORK)--Ludlow Research, a New York based equity research firm has updated its research opinion on Greenestone Healthcare Corp. (OTC:GRST), a provider of addiction treatment clinic centers in Canada, with a new tentative price target of $0.80 per share.
GRST was upgraded on the heels of their news that they have received endorsement from Ontario Police Department for their treatment of Post Traumatic Stress Disorder (PTSD), and execution of new facility that will focus specifically on this ailment. In addition, GRST is expected to report their financial earnings in the coming weeks, thus Ludlow Research is projecting positive revenue results based on their previous growth rates.
Investor Highlights
- Revenues Increasing Sharply
- Net Loss Decreasing
- On Track to Profitability
- Expanding Addiction Treatment Centers
- Target of $0.80 Issued
Greenestone Healthcare primary business is providing and managing addiction treatment centers in Canada. Currently the company operates 4 clinics, and is expected to increase these operation centers dramatically in the coming months through acquisitions. Since opening their first clinic in 2011, the company has experienced a sharp increase in revenues, and based on their growth looks primed to move into profitability within the coming months of 2013.Current
Financial Earnings
For the nine months ending Set. 30, 2012, the Company reported total revenues increased nearly 300% to $3,941,360, as compared to $1,017,431 for the same time period in 2011. For the same period, total net loss decreased nearly 33% from ($1,051,536), or ($0.07) EPS, for the nine months ending Sept. 30, 2012, compared to a net loss of ($1,767,735), or ($0.33) EPS, for the same period in 2011.
GreeneStone opened its addiction treatment center in the third quarter of 2011, and took its first patients in July and August, most of which were done at nominal or no fee. Clients began to increase in September at a steady pace and the company generated $213,035 in revenue from the treatment center during the third quarter of 2011. Revenue in the third quarter of 2012 grew to $884,036, a 315% increase over the same period the previous year, with revenue in the third quarter was only slightly better than the revenue in the second quarter. Revenue in the third quarter was impacted by a very slow period in the middle of the summer, and the company has learned that this is a traditionally slow period in the addiction treatment business and will be better prepared in the coming year for this type of slowdown.
The Company is seeking to significantly increase its capacity at its in-patient treatment facility from 36 beds to 300 beds over the next twenty four months.
Share Structure
As of Feb. 18, 2013, the Company has around 24 million shares issued and outstanding, of which around 16.5 million was held by insiders and restricted from resale, and a public float of around 7.5million shares.
Valuation Target
Based on their revenue growth rate, plans to expand bed capacity to 200 beds, launch of treatment facility for PTSD, and tight public float and technical indicators on chart, Ludlow Research has upgraded their valuation target on GRST to $0.80 per share.
Investor Mailing List and Feedback Form
If you would like to be added to GRST investor mailing list to receive updates on news, upcoming events, research notes, or to submit a question to the company, please register online at http://www.wallstreetnewscast.com/request/grst.html
(GRST)Huge News Out DD+Chart's ;]
GRST on Track to Profitability as Revenues Ramp-up from Addiction Treatment Centers
(NEW YORK)--Ludlow Research, a New York based equity research firm has initiated research opinion on Greenestone Healthcare Corp. (OTC:GRST), a provider of addiction treatment clinic centers in Canada, with a tentative price target of $0.60 to $0.75 per share.
Investor Highlights
- Revenues Increasing Sharply
- Net Loss Decreasing
- On Track to Profitability
- Expanding Addiction Treatment Centers
Greenestone Healthcare primary business is providing and managing addiction treatment centers in Canada. Currently the company operates 4 clinics, and is expected to increase these operation centers dramatically in the coming months through acquisitions. Since opening their first clinic in 2011, the company has experienced a sharp increase in revenues, and based on their growth looks primed to move into profitability within the coming months of 2013.Current
Financial Earnings
For the nine months ending Set. 30, 2012, the Company reported total revenues increased nearly 300% to $3,941,360, as compared to $1,017,431 for the same time period in 2011. For the same period, total net loss decreased nearly 33% from ($1,051,536), or ($0.07) EPS, for the nine months ending Sept. 30, 2012, compared to a net loss of ($1,767,735), or ($0.33) EPS, for the same period in 2011.
GreeneStone opened its addiction treatment center in the third quarter of 2011, and took its first patients in July and August, most of which were done at nominal or no fee. Clients began to increase in September at a steady pace and the company generated $213,035 in revenue from the treatment center during the third quarter of 2011. Revenue in the third quarter of 2012 grew to $884,036, a 315% increase over the same period the previous year, with revenue in the third quarter was only slightly better than the revenue in the second quarter. Revenue in the third quarter was impacted by a very slow period in the middle of the summer, and the company has learned that this is a traditionally slow period in the addiction treatment business and will be better prepared in the coming year for this type of slowdown.
The Company is seeking to significantly increase its capacity at its in-patient treatment facility from 36 beds to 300 beds over the next twenty four months.
Share Structure
As of Feb. 18, 2013, the Company has around 24 million shares issued and outstanding, of which around 16.5 million was held by insiders and restricted from resale, and a public float of around 7.5 million shares.
http://www.wallstreetnewscast.com/profile/grst.html
LINKS
http://www.otcmarkets.com/stock/grst/quote
http://www.otcmarkets.com/stock/GRST/news
http://www.otcmarkets.com/stock/GRST/financials
(GRST) Huge Run Coming ! DD+Chart's ;]
GRST on Track to Profitability as Revenues Ramp-up from Addiction Treatment Centers
(NEW YORK)--Ludlow Research, a New York based equity research firm has initiated research opinion on Greenestone Healthcare Corp. (OTC:GRST), a provider of addiction treatment clinic centers in Canada, with a tentative price target of $0.60 to $0.75 per share.
Investor Highlights
- Revenues Increasing Sharply
- Net Loss Decreasing
- On Track to Profitability
- Expanding Addiction Treatment Centers
Greenestone Healthcare primary business is providing and managing addiction treatment centers in Canada. Currently the company operates 4 clinics, and is expected to increase these operation centers dramatically in the coming months through acquisitions. Since opening their first clinic in 2011, the company has experienced a sharp increase in revenues, and based on their growth looks primed to move into profitability within the coming months of 2013.Current
Financial Earnings
For the nine months ending Set. 30, 2012, the Company reported total revenues increased nearly 300% to $3,941,360, as compared to $1,017,431 for the same time period in 2011. For the same period, total net loss decreased nearly 33% from ($1,051,536), or ($0.07) EPS, for the nine months ending Sept. 30, 2012, compared to a net loss of ($1,767,735), or ($0.33) EPS, for the same period in 2011.
GreeneStone opened its addiction treatment center in the third quarter of 2011, and took its first patients in July and August, most of which were done at nominal or no fee. Clients began to increase in September at a steady pace and the company generated $213,035 in revenue from the treatment center during the third quarter of 2011. Revenue in the third quarter of 2012 grew to $884,036, a 315% increase over the same period the previous year, with revenue in the third quarter was only slightly better than the revenue in the second quarter. Revenue in the third quarter was impacted by a very slow period in the middle of the summer, and the company has learned that this is a traditionally slow period in the addiction treatment business and will be better prepared in the coming year for this type of slowdown.
The Company is seeking to significantly increase its capacity at its in-patient treatment facility from 36 beds to 300 beds over the next twenty four months.
Share Structure
As of Feb. 18, 2013, the Company has around 24 million shares issued and outstanding, of which around 16.5 million was held by insiders and restricted from resale, and a public float of around 7.5 million shares.
http://www.wallstreetnewscast.com/profile/grst.html
LINKS
http://www.otcmarkets.com/stock/grst/quote
http://www.otcmarkets.com/stock/GRST/news
http://www.otcmarkets.com/stock/GRST/financials
(GRST)Huge News Out DD+Chart's ;]
GRST on Track to Profitability as Revenues Ramp-up from Addiction Treatment Centers
(NEW YORK)--Ludlow Research, a New York based equity research firm has initiated research opinion on Greenestone Healthcare Corp. (OTC:GRST), a provider of addiction treatment clinic centers in Canada, with a tentative price target of $0.60 to $0.75 per share.
Investor Highlights
- Revenues Increasing Sharply
- Net Loss Decreasing
- On Track to Profitability
- Expanding Addiction Treatment Centers
Greenestone Healthcare primary business is providing and managing addiction treatment centers in Canada. Currently the company operates 4 clinics, and is expected to increase these operation centers dramatically in the coming months through acquisitions. Since opening their first clinic in 2011, the company has experienced a sharp increase in revenues, and based on their growth looks primed to move into profitability within the coming months of 2013.Current
Financial Earnings
For the nine months ending Set. 30, 2012, the Company reported total revenues increased nearly 300% to $3,941,360, as compared to $1,017,431 for the same time period in 2011. For the same period, total net loss decreased nearly 33% from ($1,051,536), or ($0.07) EPS, for the nine months ending Sept. 30, 2012, compared to a net loss of ($1,767,735), or ($0.33) EPS, for the same period in 2011.
GreeneStone opened its addiction treatment center in the third quarter of 2011, and took its first patients in July and August, most of which were done at nominal or no fee. Clients began to increase in September at a steady pace and the company generated $213,035 in revenue from the treatment center during the third quarter of 2011. Revenue in the third quarter of 2012 grew to $884,036, a 315% increase over the same period the previous year, with revenue in the third quarter was only slightly better than the revenue in the second quarter. Revenue in the third quarter was impacted by a very slow period in the middle of the summer, and the company has learned that this is a traditionally slow period in the addiction treatment business and will be better prepared in the coming year for this type of slowdown.
The Company is seeking to significantly increase its capacity at its in-patient treatment facility from 36 beds to 300 beds over the next twenty four months.
Share Structure
As of Feb. 18, 2013, the Company has around 24 million shares issued and outstanding, of which around 16.5 million was held by insiders and restricted from resale, and a public float of around 7.5 million shares.
http://www.wallstreetnewscast.com/profile/grst.html
LINKS
http://www.otcmarkets.com/stock/grst/quote
http://www.otcmarkets.com/stock/GRST/news
http://www.otcmarkets.com/stock/GRST/financials
(GRST Issued.75 Price Target)DD+Chart's L@@K
GRST on Track to Profitability as Revenues Ramp-up from Addiction Treatment Centers
(NEW YORK)--Ludlow Research, a New York based equity research firm has initiated research opinion on Greenestone Healthcare Corp. (OTC:GRST), a provider of addiction treatment clinic centers in Canada, with a tentative price target of $0.60 to $0.75 per share.
Investor Highlights
- Revenues Increasing Sharply
- Net Loss Decreasing
- On Track to Profitability
- Expanding Addiction Treatment Centers
Greenestone Healthcare primary business is providing and managing addiction treatment centers in Canada. Currently the company operates 4 clinics, and is expected to increase these operation centers dramatically in the coming months through acquisitions. Since opening their first clinic in 2011, the company has experienced a sharp increase in revenues, and based on their growth looks primed to move into profitability within the coming months of 2013.Current
Financial Earnings
For the nine months ending Set. 30, 2012, the Company reported total revenues increased nearly 300% to $3,941,360, as compared to $1,017,431 for the same time period in 2011. For the same period, total net loss decreased nearly 33% from ($1,051,536), or ($0.07) EPS, for the nine months ending Sept. 30, 2012, compared to a net loss of ($1,767,735), or ($0.33) EPS, for the same period in 2011.
GreeneStone opened its addiction treatment center in the third quarter of 2011, and took its first patients in July and August, most of which were done at nominal or no fee. Clients began to increase in September at a steady pace and the company generated $213,035 in revenue from the treatment center during the third quarter of 2011. Revenue in the third quarter of 2012 grew to $884,036, a 315% increase over the same period the previous year, with revenue in the third quarter was only slightly better than the revenue in the second quarter. Revenue in the third quarter was impacted by a very slow period in the middle of the summer, and the company has learned that this is a traditionally slow period in the addiction treatment business and will be better prepared in the coming year for this type of slowdown.
The Company is seeking to significantly increase its capacity at its in-patient treatment facility from 36 beds to 300 beds over the next twenty four months.
Share Structure
As of Feb. 18, 2013, the Company has around 24 million shares issued and outstanding, of which around 16.5 million was held by insiders and restricted from resale, and a public float of around 7.5 million shares.
http://www.wallstreetnewscast.com/profile/grst.html
GRST Issued.75 Price Target - DD+Chart's L@@K
GRST on Track to Profitability as Revenues Ramp-up from Addiction Treatment Centers
(NEW YORK)--Ludlow Research, a New York based equity research firm has initiated research opinion on Greenestone Healthcare Corp. (OTC:GRST), a provider of addiction treatment clinic centers in Canada, with a tentative price target of $0.60 to $0.75 per share.
Investor Highlights
- Revenues Increasing Sharply
- Net Loss Decreasing
- On Track to Profitability
- Expanding Addiction Treatment Centers
Greenestone Healthcare primary business is providing and managing addiction treatment centers in Canada. Currently the company operates 4 clinics, and is expected to increase these operation centers dramatically in the coming months through acquisitions. Since opening their first clinic in 2011, the company has experienced a sharp increase in revenues, and based on their growth looks primed to move into profitability within the coming months of 2013.Current
Financial Earnings
For the nine months ending Set. 30, 2012, the Company reported total revenues increased nearly 300% to $3,941,360, as compared to $1,017,431 for the same time period in 2011. For the same period, total net loss decreased nearly 33% from ($1,051,536), or ($0.07) EPS, for the nine months ending Sept. 30, 2012, compared to a net loss of ($1,767,735), or ($0.33) EPS, for the same period in 2011.
GreeneStone opened its addiction treatment center in the third quarter of 2011, and took its first patients in July and August, most of which were done at nominal or no fee. Clients began to increase in September at a steady pace and the company generated $213,035 in revenue from the treatment center during the third quarter of 2011. Revenue in the third quarter of 2012 grew to $884,036, a 315% increase over the same period the previous year, with revenue in the third quarter was only slightly better than the revenue in the second quarter. Revenue in the third quarter was impacted by a very slow period in the middle of the summer, and the company has learned that this is a traditionally slow period in the addiction treatment business and will be better prepared in the coming year for this type of slowdown.
The Company is seeking to significantly increase its capacity at its in-patient treatment facility from 36 beds to 300 beds over the next twenty four months.
Share Structure
As of Feb. 18, 2013, the Company has around 24 million shares issued and outstanding, of which around 16.5 million was held by insiders and restricted from resale, and a public float of around 7.5 million shares.
http://www.wallstreetnewscast.com/profile/grst.html